On today's special episode, Tom flies in for a in-person discussion with Evan. They talk about the flaws of Spotify while Tom casts his sceptical eye on a new drug that has put all trial participants of rectal adenocarcinoma into remission. In his main story, Evan examines the current state of gene therapy, looks at a current gene therapeutic for Sickle Cell disease and the disadvantages of the therapy. So join us for discussion, craic and some education.